Actively Recruiting
PPK Study Based on Quantitative Pharmacology in Patients With Pamipril
Led by Qianfoshan Hospital · Updated on 2024-04-09
50
Participants Needed
1
Research Sites
161 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a non-intervention, prospective, one-arm, observational real-world clinical trial. The researchers plan to recruit at least 50 qualified patients. The main purpose of this study was to establish a population pharmacokinetic model of Pamiparib and to explore the correlation between its pharmacokinetic parameters and adverse reactions.
CONDITIONS
Official Title
PPK Study Based on Quantitative Pharmacology in Patients With Pamipril
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The age of the patient is 218 years old and less than 80 years old.
- Receive treatment with pamipalil.
- The patient signed a written informed consent form.
You will not qualify if you...
- The expected survival time may be less than the treatment cycle.
- Is being treated with other systemic trial drugs.
- There are other factors that the researchers think are not suitable for joining the group.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xin Huang
Jinan, Shandong, China, 250014
Actively Recruiting
Research Team
H
Huang Xin
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here